• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Model Number 00-1111-001-00
Device Problem Insufficient Information (3190)
Patient Problem Death (1802)
Event Date 04/02/2020
Event Type  Death  
Manufacturer Narrative
This case is received by seikagaku corporation on june 8, 2020 from the fda as mw5094703 dated june 1, 2020.According to the result of investigation for 0019x24g, there were no deviations or out-of-specifications, that could relate to the reported adverse event, found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring.We attempt to contact the reporter for the details through our us partner.
 
Event Description
On 2020-unk - a female patient received gel-one injection into the knee for osteoarthritis.On (b)(6) 2020 - she passed away.
 
Manufacturer Narrative
This is a definitive report.H10 was updated.According to our us partner on (b)(6)2020 , no additional information was expected in the result of the contact on(b)(6)2020 to the reporter.This case is received by seikagaku corporation on(b)(6)2020 from the fda as (b)(4) dated(b)(6)2020.According to the result of investigation for 0019x24g, there were no deviations or out-of-specifications, that could relate to the reported adverse event, found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring.
 
Event Description
(b)(6)2020.- a female patient received gel-one injection into the knee for osteoarthritis.(b)(6)2020 - she passed away.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
MDR Report Key10223560
MDR Text Key197301660
Report Number9612392-2020-00009
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier00087541300912
UDI-Public(01)00087541300912(17)210105(10)0019X24G(422)392
Combination Product (y/n)N
PMA/PMN Number
P080020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 06/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/05/2021
Device Model Number00-1111-001-00
Device Catalogue Number00-1111-001-00
Device Lot Number0019X24G
Was Device Available for Evaluation? No
Date Manufacturer Received07/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-